| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Studies |
University of Toronto, Departments of Physiology (F.A.P., K.S., J.R.G.C.) and Obstetrics and Gynaecology (J.R.G.C.), Medical Research Council Group in Fetal and Neonatal Health and Development (J.R.G.C.), Samuel Lunenfeld Research Institute, Mount Sinai Hospital (J.R.G.C.), Toronto, Canada
Address all correspondence and requests for reprints to: Ms. Fal Patel, Department of Physiology, 3rd Floor, Medical Sciences Building, University of Toronto, 1 Kings College Circle, Toronto, Ontario M5S 1A8, Canada. E-mail: fal.patel{at}utoronto.ca
NAD+-dependent 15-hydroxy-PG dehydrogenase (PGDH) is the
major enzyme involved in the initial inactivation of PGs, and its
activity is reduced by glucocorticoids, cortisol (F), and dexamethasone
(DEX). In turn, glucocorticoid regulation of PGDH activity in placenta
and chorion could be regulated indirectly by 11ß-hydroxysteroid
dehydrogenase (11ß-HSD) activity. In the placenta, 11ß-HSD2 is the
dominant isoform, acting as a dehydrogenase [F to cortisone
(E)]; and in chorion, 11ß-HSD1 predominates as a reductase (E to F).
The present study was designed to determine whether glucocorticoid
regulation of PGDH activity in placenta and chorion could be regulated
indirectly by 11ß-HSD activity. We obtained Percoll-purified human
placental and chorion trophoblast cells from uncomplicated term
pregnancies, cultured them for 72 h, then treated the cells with
cortisol (100 nmol/L), cortisone (1 µmol/L), or DEX (100 nmol/L), in
the presence or absence of carbenoxolone (CBX, 800 nmol/L), an
11ß-HSD inhibitor, for 24 h. Activity of PGDH was assessed by
incubation (4 h) with PGF2
(282 nmol/L) and measurement
of conversion to 13,14-dihydro-15-keto PGF2
. CBX
alone had no effect on PGDH activity in either placenta or chorion
trophoblast cells. In chorion, E significantly inhibited PGDH activity,
and this effect was reversed by addition of CBX. F and DEX
significantly inhibited PGDH, and this effect was unaltered by
coadministration of CBX. In contrast, in placenta, there was no effect
of E, or of E with CBX, on PGDH activity. However, F and DEX inhibited
PGDH, and the effect of F (but not DEX) was greater in the presence of
CBX. In conclusion, we suggest that effects of E and F on PGDH are
modified by the tissue-specific expression of 11ß-HSD isoforms.
This article has been cited by other articles:
![]() |
H.-Y. Lee, T. J. Acosta, D. J. Skarzynski, and K. Okuda Prostaglandin F2alpha Stimulates 11Beta-Hydroxysteroid Dehydrogenase 1 Enzyme Bioactivity and Protein Expression in Bovine Endometrial Stromal Cells Biol Reprod, April 1, 2009; 80(4): 657 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Michael and A. T. Papageorghiou Potential significance of physiological and pharmacological glucocorticoids in early pregnancy Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu and J. W. Funder The Evolution of Mineralocorticoid Receptors Mol. Endocrinol., July 1, 2006; 20(7): 1471 - 1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mirazi, N. Alfaidy, R. Martin, and J. R. G. Challis Effects of Dexamethasone and Sulfasalazine on Prostaglandin E2 Output by Human Placental Cells In Vitro Reproductive Sciences, January 1, 2004; 11(1): 22 - 26. [Abstract] [PDF] |
||||
![]() |
P.M. Driver, S. Rauz, E.A. Walker, M. Hewison, M.D. Kilby, and P.M. Stewart Characterization of human trophoblast as a mineralocorticoid target tissue Mol. Hum. Reprod., December 1, 2003; 9(12): 793 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Patel, J. W. Funder, and J. R. G. Challis Mechanism of Cortisol/Progesterone Antagonism in the Regulation of 15-Hydroxyprostaglandin Dehydrogenase Activity and Messenger Ribonucleic Acid Levels in Human Chorion and Placental Trophoblast Cells at Term J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2922 - 2933. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suzuki, K. Koyama, A. Darnel, H. Ishibashi, S. Kobayashi, H. Kubo, T. Suzuki, H. Sasano, and Z. S. Krozowski Dexamethasone Upregulates 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in BEAS-2B Cells Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1244 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, S. Gyomorey, S. J. Lye, W. Gibb, and J. R. G. Challis Effect of Labor on Glucocorticoid Receptor (GRTotal, GR{alpha}, and GR{beta}) Proteins in Ovine Intrauterine Tissues Reproductive Sciences, April 1, 2003; 10(3): 136 - 144. [Abstract] [PDF] |
||||
![]() |
K. Sun, P. He, and K. Yang Intracrine Induction of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression by Glucocorticoid Potentiates Prostaglandin Production in the Human Chorionic Trophoblast Biol Reprod, November 1, 2002; 67(5): 1450 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Patel and J. R. G. Challis Cortisol/Progesterone Antagonism in Regulation of 15-Hydroxysteroid Dehydrogenase Activity and mRNA Levels in Human Chorion and Placental Trophoblast Cells at Term J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 700 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Alfaidy, Z. G. Xiong, L. Myatt, Stephen. J. Lye, J. F. MacDonald, and J. R. G. Challis Prostaglandin F2{alpha} Potentiates Cortisol Production by Stimulating 11{beta}-Hydroxysteroid Dehydrogenase 1: A Novel Feedback Loop That May Contribute to Human Labor J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5585 - 5592. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.M. Driver, M.D. Kilby, I. Bujalska, E.A. Walker, M. Hewison, and P.M. Stewart Expression of 11{beta}-hydroxysteroid dehydrogenase isozymes and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies Mol. Hum. Reprod., April 1, 2001; 7(4): 357 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.L. Whittle, F.A. Patel, N. Alfaidy, A.C. Holloway, M. Fraser, S. Gyomorey, S.J. Lye, W. Gibb, and J.R.G. Challis Glucocorticoid Regulation of Human and Ovine Parturition: The Relationship Between Fetal Hypothalamic-Pituitary-Adrenal Axis Activation and Intrauterine Prostaglandin Production Biol Reprod, April 1, 2001; 64(4): 1019 - 1032. [Abstract] [Full Text] |
||||
![]() |
E. Schoof, M. Girstl, W. Frobenius, M. Kirschbaum, H. G. Dörr, W. Rascher, and J. Dötsch Decreased Gene Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 and 15-Hydroxyprostaglandin Dehydrogenase in Human Placenta of Patients with Preeclampsia J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1313 - 1317. [Abstract] [Full Text] |
||||
![]() |
W. X. Wu, X. H. Ma, G. C. S. Smith, C. A. Mecenas, S. V. Koenen, and P. W. Nathanielsz Prostaglandin dehydrogenase mRNA in baboon intrauterine tissues in late gestation and spontaneous labor Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R1082 - R1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ma, C. J. Lockwood, A. L. Bunim, D. A. Giussani, P. W. Nathanielsz, and S. Guller Cell Type-Specific Regulation of Fetal Fibronectin Expression in Amnion: Conservation of Glucocorticoid Responsiveness in Human and Nonhuman Primates Biol Reprod, June 1, 2000; 62(6): 1812 - 1817. [Abstract] [Full Text] |
||||
![]() |
G. Hirasawa, J. Takeyama, H. Sasano, K. Fukushima, T. Suzuki, Y. Muramatu, A. D. Darnel, C. Kaneko, N. Hiwatashi, T. Toyota, et al. 11{beta}-Hydroxysteroid Dehydrogenase Type II and Mineralocorticoid Receptor in Human Placenta J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1306 - 1309. [Abstract] [Full Text] |
||||
![]() |
K. J. Greenland, I. Jantke, S. Jenatschke, K. E. Bracken, C. Vinson, and B. Gellersen The Human NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Gene Promoter Is Controlled by Ets and Activating Protein-1 Transcription Factors and Progesterone Endocrinology, February 1, 2000; 141(2): 581 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Funder Editorial: 15-Hydroxyprostaglandin Dehydrogenase: Cinderella Meets Prince Serendip J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 393 - 394. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |